AfinitorDisperz (Novartis Pharmaceuticals Corporation)


Welcome to the PulseAid listing for the Afinitor drug offered from Novartis Pharmaceuticals Corporation. This Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],mTOR Inhibitor Immunosuppressant [EPC],mTOR Inhibitors [MoA],Decreased Immunologic Activity [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Novartis Pharmaceuticals Corporation
NON-PROPRIETARY NAME: everolimus
SUBSTANCE NAME: EVEROLIMUS
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],mTOR Inhibitor Immunosuppressant [EPC],mTOR Inhibitors [MoA],Decreased Immunologic Activity [PE]
ROUTE: ORAL
DOSAGE FORM: TABLET, FOR SUSPENSION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2012-08-29
END MARKETING DATE: 0000-00-00


Afinitor Disperz HUMAN PRESCRIPTION DRUG Details:

Item DescriptionAfinitor Disperz from Novartis Pharmaceuticals Corporation
LABELER NAME: Novartis Pharmaceuticals Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 2(mg/1)
START MARKETING DATE: 2012-08-29
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0078-0626_66914328-2ec0-49c4-800b-51a9ddbcc386
PRODUCT NDC: 0078-0626
APPLICATION NUMBER: NDA203985

Other EVEROLIMUS Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Novartis Pharmaceuticals CorporationZortress